1 Radiopharmaceutical Market Overview 1.1 Radiopharmaceutical Product Scope 1.2 Radiopharmaceutical Segment by Type 1.2.1 Global Radiopharmaceutical Sales by Type (2020-2026) 1.2.2 Actinium-225 1.2.3 Lutetium-177 1.2.4 Radium-223 1.2.5 Holmium-166 1.2.6 Other 1.3 Radiopharmaceutical Segment by Application 1.3.1 Global Radiopharmaceutical Sales Comparison by Application (2020-2026) 1.3.2 Oncology 1.3.3 Cardiology 1.3.4 Other 1.4 Radiopharmaceutical Market Estimates and Forecasts (2015-2026) 1.4.1 Global Radiopharmaceutical Sales Growth Rate (2015-2026) 1.4.2 Global Radiopharmaceutical Revenue and Growth Rate (2015-2026) 1.4.3 Global Radiopharmaceutical Price Trends (2015-2026) 2 Radiopharmaceutical Estimate and Forecast by Region 2.1 Global Radiopharmaceutical Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Radiopharmaceutical Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Radiopharmaceutical Sales Market Share by Region (2015-2020) 2.2.2 Global Radiopharmaceutical Revenue Market Share by Region (2015-2020) 2.3 Global Radiopharmaceutical Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Radiopharmaceutical Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Radiopharmaceutical Estimates and Projections (2015-2026) 2.4.2 Europe Radiopharmaceutical Estimates and Projections (2015-2026) 2.4.3 China Radiopharmaceutical Estimates and Projections (2015-2026) 2.4.4 Japan Radiopharmaceutical Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Radiopharmaceutical Estimates and Projections (2015-2026) 2.4.6 India Radiopharmaceutical Estimates and Projections (2015-2026) 3 Global Radiopharmaceutical Competition Landscape by Players 3.1 Global Top Radiopharmaceutical Players by Sales (2015-2020) 3.2 Global Top Radiopharmaceutical Players by Revenue (2015-2020) 3.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2019) 3.4 Global Radiopharmaceutical Average Price by Company (2015-2020) 3.5 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Radiopharmaceutical Players (Opinion Leaders) 4 Global Radiopharmaceutical Market Size by Type 4.1 Global Radiopharmaceutical Historic Market Review by Type (2015-2020) 4.1.1 Global Radiopharmaceutical Sales Market Share by Type (2015-2020) 4.1.2 Global Radiopharmaceutical Revenue Market Share by Type (2015-2020) 4.1.3 Global Radiopharmaceutical Price by Type (2015-2020) 4.2 Global Radiopharmaceutical Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Radiopharmaceutical Sales Forecast by Type (2021-2026) 4.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2021-2026) 4.2.3 Global Radiopharmaceutical Price Forecast by Type (2021-2026) 5 Global Radiopharmaceutical Market Size by Application 5.1 Global Radiopharmaceutical Historic Market Review by Application (2015-2020) 5.1.1 Global Radiopharmaceutical Sales Market Share by Application (2015-2020) 5.1.2 Global Radiopharmaceutical Revenue Market Share by Application (2015-2020) 5.1.3 Global Radiopharmaceutical Price by Application (2015-2020) 5.2 Global Radiopharmaceutical Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Radiopharmaceutical Sales Forecast by Application (2021-2026) 5.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2021-2026) 5.2.3 Global Radiopharmaceutical Price Forecast by Application (2021-2026) 6 United States Radiopharmaceutical Market Facts & Figures 6.1 United States Radiopharmaceutical Sales Market Share by Company (2015-2020) 6.2 United States Radiopharmaceutical Sales Market Share by Type (2015-2020) 6.3 United States Radiopharmaceutical Sales Market Share by Application (2015-2020) 7 Europe Radiopharmaceutical Market Facts & Figures 7.1 Europe Radiopharmaceutical Sales Market Share by Company (2015-2020) 7.2 Europe Radiopharmaceutical Sales Market Share by Type (2015-2020) 7.3 Europe Radiopharmaceutical Sales Market Share by Application (2015-2020) 8 China Radiopharmaceutical Market Facts & Figures 8.1 China Radiopharmaceutical Sales Market Share by Company (2015-2020) 8.2 China Radiopharmaceutical Sales Market Share by Type (2015-2020) 8.3 China Radiopharmaceutical Sales Market Share by Application (2015-2020) 9 Japan Radiopharmaceutical Market Facts & Figures 9.1 Japan Radiopharmaceutical Sales Market Share by Company (3015-3030) 9.2 Japan Radiopharmaceutical Sales Market Share by Type (2015-2020) 9.3 Japan Radiopharmaceutical Sales Market Share by Application (2015-2020) 10 Southeast Asia Radiopharmaceutical Market Facts & Figures 10.1 Southeast Asia Radiopharmaceutical Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Radiopharmaceutical Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Radiopharmaceutical Sales Market Share by Application (2015-2020) 11 India Radiopharmaceutical Market Facts & Figures 11.1 India Radiopharmaceutical Sales Market Share by Company (2015-2020) 11.2 India Radiopharmaceutical Sales Market Share by Type (2015-2020) 11.3 India Radiopharmaceutical Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Radiopharmaceutical Business 12.1 Bracco Imaging 12.1.1 Bracco Imaging Corporation Information 12.1.2 Bracco Imaging Business Overview 12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Bracco Imaging Radiopharmaceutical Products Offered 12.1.5 Bracco Imaging Recent Development 12.2 Bayer 12.2.1 Bayer Corporation Information 12.2.2 Bayer Business Overview 12.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Bayer Radiopharmaceutical Products Offered 12.2.5 Bayer Recent Development 12.3 Mallinckrodt 12.3.1 Mallinckrodt Corporation Information 12.3.2 Mallinckrodt Business Overview 12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Mallinckrodt Radiopharmaceutical Products Offered 12.3.5 Mallinckrodt Recent Development 12.4 Nordion 12.4.1 Nordion Corporation Information 12.4.2 Nordion Business Overview 12.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Nordion Radiopharmaceutical Products Offered 12.4.5 Nordion Recent Development 12.5 Triad Isotopes 12.5.1 Triad Isotopes Corporation Information 12.5.2 Triad Isotopes Business Overview 12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Triad Isotopes Radiopharmaceutical Products Offered 12.5.5 Triad Isotopes Recent Development 12.6 Lantheus 12.6.1 Lantheus Corporation Information 12.6.2 Lantheus Business Overview 12.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Lantheus Radiopharmaceutical Products Offered 12.6.5 Lantheus Recent Development 12.7 IBA Group 12.7.1 IBA Group Corporation Information 12.7.2 IBA Group Business Overview 12.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.7.4 IBA Group Radiopharmaceutical Products Offered 12.7.5 IBA Group Recent Development 12.8 GE Healthcare 12.8.1 GE Healthcare Corporation Information 12.8.2 GE Healthcare Business Overview 12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.8.4 GE Healthcare Radiopharmaceutical Products Offered 12.8.5 GE Healthcare Recent Development 12.9 China Isotope & Radiation 12.9.1 China Isotope & Radiation Corporation Information 12.9.2 China Isotope & Radiation Business Overview 12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered 12.9.5 China Isotope & Radiation Recent Development 12.10 Jubilant Pharma 12.10.1 Jubilant Pharma Corporation Information 12.10.2 Jubilant Pharma Business Overview 12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Jubilant Pharma Radiopharmaceutical Products Offered 12.10.5 Jubilant Pharma Recent Development 12.11 Eli Lilly 12.11.1 Eli Lilly Corporation Information 12.11.2 Eli Lilly Business Overview 12.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Eli Lilly Radiopharmaceutical Products Offered 12.11.5 Eli Lilly Recent Development 12.12 Advanced Accelerator Applications 12.12.1 Advanced Accelerator Applications Corporation Information 12.12.2 Advanced Accelerator Applications Business Overview 12.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Advanced Accelerator Applications Radiopharmaceutical Products Offered 12.12.5 Advanced Accelerator Applications Recent Development 12.13 SIEMENS 12.13.1 SIEMENS Corporation Information 12.13.2 SIEMENS Business Overview 12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.13.4 SIEMENS Radiopharmaceutical Products Offered 12.13.5 SIEMENS Recent Development 12.14 Dongcheng 12.14.1 Dongcheng Corporation Information 12.14.2 Dongcheng Business Overview 12.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Dongcheng Radiopharmaceutical Products Offered 12.14.5 Dongcheng Recent Development 12.15 Navidea 12.15.1 Navidea Corporation Information 12.15.2 Navidea Business Overview 12.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Navidea Radiopharmaceutical Products Offered 12.15.5 Navidea Recent Development 13 Radiopharmaceutical Manufacturing Cost Analysis 13.1 Radiopharmaceutical Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Radiopharmaceutical 13.4 Radiopharmaceutical Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Radiopharmaceutical Distributors List 14.3 Radiopharmaceutical Customers 15 Market Dynamics 15.1 Radiopharmaceutical Market Trends 15.2 Radiopharmaceutical Opportunities and Drivers 15.3 Radiopharmaceutical Market Challenges 15.4 Radiopharmaceutical Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Radiopharmaceutical Sales (M Doses) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Radiopharmaceutical Sales (M Doses) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Radiopharmaceutical Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Radiopharmaceutical Sales (M Doses) by Region (2015-2020) Table 5. Global Radiopharmaceutical Sales Market Share by Region (2015-2020) Table 6. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Radiopharmaceutical Revenue Share by Region (2015-2020) Table 8. Global Radiopharmaceutical Sales (M Doses) Forecast by Region (2021-2026) Table 9. Global Radiopharmaceutical Sales Market Share Forecast by Region (2021-2026) Table 10. Global Radiopharmaceutical Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Radiopharmaceutical Revenue Share Forecast by Region (2021-2026) Table 12. Global Radiopharmaceutical (M Doses) of Key Companies (2015-2020) Table 13. Global Radiopharmaceutical Sales Share by Company (2015-2020) Table 14. Global Radiopharmaceutical Revenue (US$ Million) by Company (2015-2020) Table 15. Global Radiopharmaceutical Revenue Share by Company (2015-2020) Table 16. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2019) Table 17. Global Radiopharmaceutical Average Price (USD/Dose) of Key Company (2015-2020) Table 18. Manufacturers Radiopharmaceutical Manufacturing Sites and Area Served Table 19. Manufacturers Radiopharmaceutical Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Radiopharmaceutical Players Table 22. Global Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 23. Global Radiopharmaceutical Sales Share by Type (2015-2020) Table 24. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Radiopharmaceutical Price (M Doses) by Type (2015-2020) Table 26. Global Radiopharmaceutical Sales Share by Type (2021-2026) Table 27. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Radiopharmaceutical Revenue Share by Type (2021-2026) Table 29. Global Radiopharmaceutical Price (M Doses) by Type (2021-2026) Table 30. Global Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 31. Global Radiopharmaceutical Sales Share by Application (2015-2020) Table 32. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Radiopharmaceutical Price (M Doses) by Application (2015-2020) Table 34. Global Radiopharmaceutical Sales (M Doses) by Application (2021-2026) Table 35. Global Radiopharmaceutical Sales Share by Application (2021-2026) Table 36. Global Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Radiopharmaceutical Revenue Share by Application (2021-2026) Table 38. Global Radiopharmaceutical Price (M Doses) by Application (2021-2026) Table 39. United States Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 40. United States Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 41. United States Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 42. United States Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 43. United States Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 44. United States Radiopharmaceutical Sales Market Share by Application (2015-2020) Table 45. Europe Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 46. Europe Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 47. Europe Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 48. Europe Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 49. Europe Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 50. Europe Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 51. China Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 52. China Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 53. China Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 54. China Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 55. China Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 56. China Radiopharmaceutical Sales Market Share by Application (2015-2020) Table 57. Japan Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 58. Japan Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 59. Japan Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 60. Japan Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 61. Japan Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 62. Japan Radiopharmaceutical Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 64. Southeast Asia Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 66. Southeast Asia Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 68. Southeast Asia Radiopharmaceutical Sales Market Share by Application (2015-2020) Table 69. India Radiopharmaceutical Sales (M Doses) by Company (2015-2020) Table 70. India Radiopharmaceutical Sales Market Share by Company (2015-2020) Table 71. India Radiopharmaceutical Sales (M Doses) by Type (2015-2020) Table 72. India Radiopharmaceutical Sales Market Share by Type (2015-2020) Table 73. India Radiopharmaceutical Sales (M Doses) by Application (2015-2020) Table 74. India Radiopharmaceutical Sales Market Share by Application (2015-2020) Table 75. Bracco Imaging Corporation Information Table 76. Bracco Imaging Description and Business Overview Table 77. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 78. Bracco Imaging Radiopharmaceutical Product Table 79. Bracco Imaging Recent Development Table 80. Bayer Corporation Information Table 81. Bayer Description and Business Overview Table 82. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 83. Bayer Radiopharmaceutical Product Table 84. Bayer Recent Development Table 85. Mallinckrodt Corporation Information Table 86. Mallinckrodt Description and Business Overview Table 87. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 88. Mallinckrodt Radiopharmaceutical Product Table 89. Mallinckrodt Recent Development Table 90. Nordion Corporation Information Table 91. Nordion Description and Business Overview Table 92. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 93. Nordion Radiopharmaceutical Product Table 94. Nordion Recent Development Table 95. Triad Isotopes Corporation Information Table 96. Triad Isotopes Description and Business Overview Table 97. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 98. Triad Isotopes Radiopharmaceutical Product Table 99. Triad Isotopes Recent Development Table 100. Lantheus Corporation Information Table 101. Lantheus Description and Business Overview Table 102. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 103. Lantheus Radiopharmaceutical Product Table 104. Lantheus Recent Development Table 105. IBA Group Corporation Information Table 106. IBA Group Description and Business Overview Table 107. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 108. IBA Group Radiopharmaceutical Product Table 109. IBA Group Recent Development Table 110. GE Healthcare Corporation Information Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 112. GE Healthcare Description and Business Overview Table 113. GE Healthcare Radiopharmaceutical Product Table 114. GE Healthcare Recent Development Table 115. China Isotope & Radiation Corporation Information Table 116. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 117. China Isotope & Radiation Description and Business Overview Table 118. China Isotope & Radiation Radiopharmaceutical Product Table 119. China Isotope & Radiation Recent Development Table 120. Jubilant Pharma Corporation Information Table 121. Jubilant Pharma Description and Business Overview Table 122. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 123. Jubilant Pharma Radiopharmaceutical Product Table 124. Jubilant Pharma Recent Development Table 125. Eli Lilly Corporation Information Table 126. Eli Lilly Description and Business Overview Table 127. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 128. Eli Lilly Radiopharmaceutical Product Table 129. Eli Lilly Recent Development Table 130. Advanced Accelerator Applications Corporation Information Table 131. Advanced Accelerator Applications Description and Business Overview Table 132. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 133. Advanced Accelerator Applications Radiopharmaceutical Product Table 134. Advanced Accelerator Applications Recent Development Table 135. SIEMENS Corporation Information Table 136. SIEMENS Description and Business Overview Table 137. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 138. SIEMENS Radiopharmaceutical Product Table 139. SIEMENS Recent Development Table 140. Dongcheng Corporation Information Table 141. Dongcheng Description and Business Overview Table 142. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 143. Dongcheng Radiopharmaceutical Product Table 144. Dongcheng Recent Development Table 145. Navidea Corporation Information Table 146. Navidea Description and Business Overview Table 147. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020) Table 148. Navidea Radiopharmaceutical Product Table 149. Navidea Recent Development Table 150. Production Base and Market Concentration Rate of Raw Material Table 151. Key Suppliers of Raw Materials Table 152. Radiopharmaceutical Distributors List Table 153. Radiopharmaceutical Customers List Table 154. Radiopharmaceutical Market Key Trends Table 155. Radiopharmaceutical Key Opportunities and Drivers Table 156. Radiopharmaceutical Market Challenges Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Radiopharmaceutical Product Picture Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Radiopharmaceutical Market Share by Application in 2020 & 2026 Figure 6. Oncology Examples Figure 7. Cardiology Examples Figure 8. Other Examples Figure 9. Global Radiopharmaceutical Sales (M Doses) Growth Rate (2015-2026) Figure 10. Global Radiopharmaceutical Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Radiopharmaceutical Price Trends Growth Rate (2015-2026) (USD/Dose) Figure 12. Global Radiopharmaceutical Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Radiopharmaceutical Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Radiopharmaceutical Sales (M Doses) Growth Rate (2015-2026) Figure 16. Europe Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Radiopharmaceutical Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Radiopharmaceutical Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Radiopharmaceutical Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical 2015 & 2019 Figure 27. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Radiopharmaceutical Revenue Share by Type (2015-2020) Figure 29. Global Radiopharmaceutical Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Radiopharmaceutical Revenue Share by Application (2015-2020) Figure 31. Global Radiopharmaceutical Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Radiopharmaceutical Sales Market Share by Type in 2019 Figure 33. United States Radiopharmaceutical Sales Market Share by Type in 2019 Figure 34. Europe Radiopharmaceutical Sales Market Share by Company in 2019 Figure 35. Europe Radiopharmaceutical Sales Market Share by Type in 2019 Figure 36. Europe Radiopharmaceutical Sales Market Share by Application in 2019 Figure 37. China Radiopharmaceutical Sales Market Share by Company in 2019 Figure 38. China Radiopharmaceutical Sales Market Share by Type in 2019 Figure 39. China Radiopharmaceutical Sales Market Share by Application in 2019 Figure 40. Japan Radiopharmaceutical Sales Market Share by Company in 2019 Figure 41. Japan Radiopharmaceutical Sales Market Share by Type in 2019 Figure 42. Japan Radiopharmaceutical Sales Market Share by Application in 2019 Figure 43. Southeast Asia Radiopharmaceutical Sales Market Share by Company in 2019 Figure 44. Southeast Asia Radiopharmaceutical Sales Market Share by Type in 2019 Figure 45. Southeast Asia Radiopharmaceutical Sales Market Share by Application in 2019 Figure 46. India Radiopharmaceutical Sales Market Share by Company in 2019 Figure 47. India Radiopharmaceutical Sales Market Share by Type in 2019 Figure 48. India Radiopharmaceutical Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Radiopharmaceutical Figure 51. Manufacturing Process Analysis of Radiopharmaceutical Figure 52. Radiopharmaceutical Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Bracco Imaging Bayer Mallinckrodt Nordion Triad Isotopes Lantheus IBA Group GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Advanced Accelerator Applications SIEMENS Dongcheng Navidea